Arbutus to Present AB-729 and AB-836 Data at EASL Congress :

WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging...

Related Keywords

Canada , Vienna , Wien , Austria , United States , Canadian , Fung Yuen , N Acetylgalactosamine Galnac , Lisam Caperelli , Christinel Espiritu , Securities Exchange , Arbutus Biopharma Corporation Nasdaq , World Health Organization , Biopharma Corporation , European Association , Abstract Number , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports , Nasdaq Abus , Arbutus Biopharma Corporation , Arbutus , Arbutus Biopharma , Asl Congress 2023 , Abstracts Accepted , Oster Presentatons , Gbv ,